FDA Approves Lipfendra: A Game-Changer in Cholesterol Treatment
Lipfendra, the first oral PCSK9 inhibitor, gains FDA approval, offering a non-invasive alternative for high cholesterol treatment. Discover its impact!
Lipfendra, the first oral PCSK9 inhibitor, gains FDA approval, offering a non-invasive alternative for high cholesterol treatment. Discover its impact!
Discover how AI might reshape our understanding of the Fermi Paradox and the search for intelligent life in the universe.
The KardiaMobile 6L Max is among a new wave of portable EKG devices empowering consumers to monitor cardiac health outside the doctor's office.
New research reveals over 91% of adults with ADHD use masking behaviors to fit in socially, but these strategies cause exhaustion and worsen symptoms.
A Yale neurologist discusses key stroke risk factors, prevention strategies including the DASH diet, and emerging rehabilitation technologies in comprehensive...
New research suggests common blood pressure medications may increase kidney disease risk by 33% in type 2 diabetes patients, challenging current treatment...
Review of 22 studies finds naturally occurring trans fats in dairy products don't increase heart disease or diabetes risk, unlike industrial trans fats.
A longevity doctor identifies five often-overlooked heart attack symptoms in women that are frequently misdiagnosed as stress or digestive issues.
NFHS-6 survey shows 30.7% of Indian women aged 15-49 are overweight or obese, up from 24%, signaling a growing public health crisis linked to lifestyle changes.
New research shows 6.7 million American children live with unsecured firearms, up from 4.5 million in 2015, as parents relax gun safety during teens'...
Finnish research reveals significant barriers to dental care for disabled patients, including inaccessible facilities and undertrained professionals, while...
Mayo Clinic study reveals hormone therapy use for menopause dropped from 4.4% to 1.7% between 2007-2023, despite strong evidence of safety and effectiveness.